Evaluation of in vitro/in vivo anti-diabetic effects and identification of compounds from Physalis alkekengi

Fitoterapia

Volumn 127, Issue , 2018, Pages 129-137

  Hu, Xiao Fang ^a   Zhang, Qiang ^a   Zhang, Pan Pan ^a   Sun, Li Juan ^a   Liang, Ji Chao ^a   Morris Natschke, Susan L ^b   Chen, Yong ^a   Lee, Kuo Hsiung ^b,c  

^a HUBEI UNIVERSITY   (China)

^b UNC Hamner Institute for Drug Safety Sciences   (United States)

^c CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Anti diabetic; Antioxidant; CYP2E1; GLUT4; Physalis alkekengi

Indexed keywords

ALPHA GLUCOSIDASE; ALPHA GLUCOSIDASE INHIBITOR; ANTIDIABETIC AGENT; ANTIOXIDANT; ASCORBIC ACID; BETA ACTIN; CHOLESTEROL; CYTOCHROME P450 2E1; GLUCOSE; GLUCOSE TRANSPORTER 4; INSULIN; MESSENGER RNA; PHYSALIS ALKEKENGI EXTRACT; PLANT EXTRACT; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; FLAVONOID; POLYPHENOL;

ABTS RADICAL SCAVENGING ASSAY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIDIABETIC ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; CHEMICAL COMPOSITION; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; ELECTROSPRAY MASS SPECTROMETRY; FERRIC REDUCING ANTIOXIDANT POWER ASSAY; GLUCOSE BLOOD LEVEL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HOMEOSTASIS MODEL ASSESSMENT; IN VITRO STUDY; IN VIVO STUDY; INSULIN BLOOD LEVEL; INSULIN SENSITIVITY; MALE; MEDICINAL PLANT; NONHUMAN; ORAL GLUCOSE TOLERANCE TEST; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PHYSALIS ALKEKENGI; PRIORITY JOURNAL; PROADIPOCYTE; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION; 3T3-L1 CELL LINE; AERIAL PLANT PART; ANIMAL; CHEMISTRY; EXPERIMENTAL DIABETES MELLITUS; FRUIT; GLUCOSE TOLERANCE TEST; HEP-G2 CELL LINE; HUMAN; INSULIN RESISTANCE; ISOLATION AND PURIFICATION; MOUSE; PHYSALIS; SPRAGUE DAWLEY RAT;

3T3-L1 CELLS; ANIMALS; ANTIOXIDANTS; DIABETES MELLITUS, EXPERIMENTAL; FLAVONOIDS; FRUIT; GLUCOSE TOLERANCE TEST; HEP G2 CELLS; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN RESISTANCE; MALE; MICE; OXIDATIVE STRESS; PHYSALIS; PLANT COMPONENTS, AERIAL; POLYPHENOLS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 85042405225     PISSN: 0367326X     EISSN: 18736971     Source Type: Journal    
DOI: 10.1016/j.fitote.2018.02.015     Document Type: Article

References (38)

1. Yang, H., Han, S., Zhao, D., Wang, G., Adjuvant effect of polysaccharide from fruits of Physalis alkekengi L. in DNA vaccine against systemic candidiasis. Carbohydr. Polym. 109 (2014), 77–84.
2. Hou, Y., Jiang, J.G., Origin and concept of medicine food homology and its application in modern functional foods. Food Funct. 4 (2013), 1727–1741.
3. Li, A.L., Chen, B.J., Li, G.H., Zhou, M.X., Li, Y.R., Ren, D.M., Lou, H.X., Wang, X.N., Shen, T., Physalis alkekengi L. var. franchetii (Mast.) Makino: an ethnomedical, phytochemical and pharmacological review. J. Ethnopharmacol. 210((2018), 260–274.
4. Guo, Y., Li, S.J., Li, J.X., Ren, Z.Y., Chen, F., Wang, X.W., Anti-hyperglycemic activity of polysaccharides from calyx of Physalis alkekengi var. franchetii Makino on alloxan-induced mice. Int. J. Biol. Macromol. 99((2017), 249–257.
5. Hassan, A.I., Ghoneim, M.A.M., A possible inhibitory effect of Physalis (Physalis pubescens L.) on diabetes in male rats. World Appl. Sci. J. 21:5 (2013), 681–688.
6. Sanchooli, N., Antidiabetic properties of Physalis alkekengi extract in alloxan-induced diabetic rats. Res. J. Pharm. Biol. Chem. Sci. 2:3 (2011), 168–173.
7. Asano, N., Kato, A., Oseki, K., Kizu, H., Matsui, K., Calystegins of Physalis alkekengi var. francheti (Solanaceae). Structure determination and their glycosidase inhibitory activities. Eur. J. Biochem. 229:2 (1995), 369–376.
8. Vessal, M., Mostafavi-Pour, Z., Kooshesh, F., Age and sex dependence of the effects of an aqueous extract of Physalis alkekengi fruits on rat hepatic glucose 6-P dehydrogenase activity. Comp. Biochem. Physiol. B Biochem. Mol. Biol. 111:4 (1995), 675–680.
9. Tong, H., Liang, Z., Wang, G., Structural characterization and hypoglycemic activity of a polysaccharide isolated from the fruit of Physalis alkekengi L. Carbohydr. Polym. 71 (2008), 316–323.
10. Govers, R., Molecular mechanisms of GLUT4 regulation in adipocytes. Diabete Metab. 40:6 (2014), 400–410.
11. Huang, B., Ke, H., He, J., Ban, X., Zeng, H., Wang, Y., Extracts of Halenia elliptica exhibit antioxidant properties in vitro and in vivo. Food Chem. Toxicol. 49:1 (2011), 185–190.
12. Valencia-Olvera, A.C., Morán, J., Camacho-Carranza, R., Prospéro-García, O., Espinosa-Aguirre, J.J., CYP2E1 induction leads to oxidative stress and cytotoxicity in glutathione-depleted cerebellar granule neurons. Toxicol. in Vitro 28:7 (2014), 1206–1214.
13. Armoni, M., Harel, C., Ramdas, M., Karnieli, E., CYP2E1 impairs GLUT4 gene expression and function: NRF2 as a possible mediator. Horm. Metab. Res. 46:7 (2014), 477–483.
14. Horváth, B., Mukhopadhyay, P., Haskó G., Pacher, P., The endocannabinoid system and plant-derived cannabinoids in diabetes and diabetic complications. J. Pathol. 180:2 (2012), 432–442.
15. Raun, K., von Voss, P., Gotfredsen, C.F., Golozoubova, V., Rolin, B., Knudsen, L.B., Liraglutide, a long-acting glucagon-like peptide-1 analog, reduces body weight and food intake in obese candy-fed rats, whereas a dipeptidyl peptidase-IV inhibitor, vildagliptin, does not. Diabetes 56:1 (2007), 8–15.
16. Woodcroft, K.J., Hafner, M.S., Novak, R.F., Insulin signaling in the transcriptional and posttranscriptional regulation of CYP2E1 expression. Hepatology 35 (2002), 263–273.
17. Kennedy, L., Mehl, T., Riley, W., Merimee, T., Non-enzymatically glycosylated serum protein in diabetes mellitus: an index of short-term glycaemia. Diabetologia 21:2 (1981), 94–98.
18. Rodriguez-Capote, K., Tovell, K., Holmes, D., Dayton, J., Higgins, T.N., Analytical evaluation of the Diazyme glycated serum protein assay on the siemens ADVIA 1800: comparison of results against HbA1c for diagnosis and management of diabetes. J. Diabet. Sci. Technol. 9:2 (2015), 192–199.
19. Singh, J., Kakkar, P., Modulation of liver function, antioxidant responses, insulin resistance and glucose transport by Oroxylum indicum stem bark in STZ induced diabetic rats. Food Chem. Toxicol. 62((2013), 722–731.
20. Xu, X., Li, F., Zhang, X., Wu, Z., Li, D., In vitro synergistic antioxidant activity and identification of antioxidant components from Astragalus membranaceus and Paeonia lactiflora. PLoS One(5), 2014, e96780.
21. Yan, J., Zhang, G., Pan, J., Wang, Y., α-Glucosidase inhibition by luteolin: kinetics, interaction and molecular docking. Int. J. Biol. Macromol. 64((2014), 213–223.
22. Loh, K., Deng, H., Fukushima, A., Tiganis, T., Reactive oxygen species enhance insulin sensitivity. Cell Metab. 10:4 (2009), 260–272.
23. Zhao, Y., Lu, N., Li, H., Zhang, Y., Gao, Z., Gong, Y., High glucose induced human umbilical vein endothelial cell injury: involvement of protein tyrosine nitration. Mol. Cell. Biochem. 311 (2008), 19–29.
24. Wang, F., Zhao, S., Li, F., Zhang, B., Qu, Y., Sun, T., Luo, T., Li, D., Investigation of antioxidant interactions between Radix Astragali and Cimicifuga foetida and identification of synergistic antioxidant compounds. PLoS One, 9(1), 2014, e87221.
25. Ahn, T., Yun, C.H., Oh, D.B., Tissue-specific effect of ascorbic acid supplementation on the expression of cytochrome P450 2E1 and oxidative stress in streptozotocin-induced diabetic rats. Toxicol. Lett. 166:1 (2006), 27–36.
26. Chen, M.L., Ip, S.P., Tsai, S.H., Ko, K.M., Che, C.T., Biochemical mechanism of Wu-Zi-Yan-Zong-Wan, a traditional Chinese herbal formula, against alcohol-induced oxidative damage in CYP2E1 cDNA-transfected HepG2 (E47) cells. J. Ethnopharmacol. 128:1 (2010), 116–122.
27. Wu, D., Wang, X., Zhou, R., Cederbaum, A., CYP2E1 enhances ethanol-induced lipid accumulation but impairs autophaghy in HepG2 E47 cells. Biochem. Biophys. Res. Commu. 402:1 (2010), 116–122.
28. Zhang, C.H., Yu, R.Y., Liu, Y.H., Tu, X.Y., Tu, J., Wang, Y.S., Xu, G.L., Interaction of baicalin with berberine for glucose uptake in 3T3-L1 adipocytes and HepG2 hepatocytes. J. Ethnopharmacol. 151:2 (2014), 864–872.
29. Koren-Gluzer, M., Aviram, M., Hayek, T., Paraoxonase1 (PON1) reduces insulin resistance in mice fed a high-fat diet, and promotes GLUT4 overexpression in myocytes, via the IRS-1/Akt pathway. Atherosclerosis 229:1 (2013), 71–78.
30. Yao, H.T., Lin, P., Chang, Y.W., Chen, C.T., Chiang, M.T., Chang, L., Kuo, Y.C., Tsai, H.T., Yeh, T.K., Effect of taurine supplementation on cytochrome P450 2E1 and oxidative stress in the liver and kidneys of rats with streptozotocin-induced diabetes. Toxicology 47:7 (2009), 1703–1709.
31. Shimojo, N., Ishizaki, T., Imaoka, S., Funae, Y., Fujii, S., Okuda, K., Changes in amounts of cytochrome P450 isozymes and levels of catalytic activities in hepatic and renal microsomes of rats with streptozocin-induced diabetes. Biochem. Pharmacol. 46 (1993), 621–627.
32. Shen, Y., Zhao, Y., Zheng, D., Chang, X., Ju, S., Guo, L., Effects of orexin A on GLUT4 expression and lipid content via MAPK signaling in 3T3-L1 adipocytes. J. Steroid Biochem. Mol. Biol. 138((2013), 376–383.
33. Kraegen, E.W., Clark, P.W., Jenkins, A.B., Daley, E.A., Chisholm, D.J., Storlien, L.H., Development of muscle insulin resistance after liver insulin resistance in high-fat–fed rats. Diabetes 40:11 (1991), 1397–1403.
34. Liu, Y.R., Li, W.G., Chen, L.F., Xiao, B.K., Yang, J.Y., Yang, L., Zhang, C.G., Huang, R.Q., Dong, J.X., ABTS+ scavenging potency of selected flavonols from Hypericum perforatum L. by HPLC-ESI/MS QQQ: Reaction observation, adduct characterization and scavenging activity determination. Food Res. Int. 58 (2014), 47–58.
35. López-Alarcón, C., Denicola, A., Evaluating the antioxidant capacity of natural products: a review on chemical and cellular-based assays. Anal. Chim. Acta 763 (2013), 1–10.
36. Matsui, T., Ueda, T., Oki, T., Sugita, K., Terahara, N., Matsumoto, K., α-Glucosidase inhibitory action of natural acylated anthocyanins. 1. Survey of natural pigments with potent inhibitory activity. J. Agric. Food Chem. 49:4 (2001), 1948–1951.
37. Ren, B., Qin, W., Wu, F., Wang, S., Pan, C., Wang, L., Zeng, B., Ma, S., Liang, J., Apigenin and naringenin regulate glucose and lipid metabolism, and ameliorate vascular dysfunction in type 2 diabetic rats. Eur. J. Pharmacol. 15:773 (2016), 13–23.
38. Semaan, D.G., Igoli, J.O., Young, L., Marrero, E., Gray, A.I., Rowan, E.G., In vitro anti-diabetic activity of flavonoids and pheophytins from Allophylus cominia Sw. on PTP1B, DPPIV, alpha-glucosidase and alpha-amylase enzymes. J. Ethnopharmacol. 5:203 (2017), 39–46.